Skip to main content
Start date: 


54 Participating sites in Europe
6 European countries
6,000 Patients enrolled in the ЕU

PNEUMO is an international observational trial which seeks deeper understanding of the risk of specific pneumococcal serotypes in patients with community-acquired pneumonia (CAP), as well as the associated morbidity and mortality. This knowledge can inform vaccine development and public health policy. Exploratory objectives were added to assess the impact of SARS-COV-2 pandemic.

Ecraid handles the trial's management and site selection in the EU. The CLIN-Net team has selected a total of 54 sites in 6 countries: Spain, France, Italy, Germany, the UK, and the Netherlands.

UMC Utrecht is the trial's sponsor for the EU. Funding is provided by MSD.